World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
21774
World Ranking
18057
National Ranking
1648

Overview

David R. Owens is affiliated with Swansea University in the United Kingdom. Their research is situated mainly in the field of Medicine, with a specific focus on Endocrinology, Diabetes and Metabolism. Their scholarly output reflects an emphasis on diabetes-related topics, spanning clinical treatment, disease management, and complications arising from diabetes.

Owens's work has contributed to several important areas within diabetes research. The main topics covered include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Retinal Imaging and Analysis
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Retinal Diseases and Treatments
  • Metabolism, Diabetes, and Cancer

The scientist has authored papers in numerous publication venues, frequently contributing to journals specializing in diabetes and metabolism. Frequent publication venues include:

  • Diabetes Obesity and Metabolism
  • Diabetes & Metabolism
  • Diabetes Research and Clinical Practice
  • Diabetes
  • Diabetes Care

Among the recent papers are:

  • Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses, 2020, Diabetologia
  • Review of methods for detecting glycemic disorders, 2020, Diabetes Research and Clinical Practice
  • Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy, 2023, Cochrane Database of Systematic Reviews
  • Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype, 2020, Nature Reviews Endocrinology
  • The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications, 2020, Diabetes Obesity and Metabolism

Owens has collaborated extensively with several coauthors, indicating active engagement in multidisciplinary research teams. Frequent coauthors include:

  • C Colette
  • Louis Monnier
  • Rebecca Thomas
  • Geremia B. Bolli
  • Stephen D. Luzio

Their body of work addresses complications of diabetes such as vascular issues and proliferative diabetic retinopathy, alongside investigations into glycemic disorder detection and preventive lifestyle interventions for type 2 diabetes mellitus (T2DM). Additionally, there is significant focus on advancements in insulin therapies, emphasizing the development and clinical implications of prandial insulins administered subcutaneously.

Best Publications

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

    D R Owens;P A Coates;S D Luzio;J P Tinbergen

  • The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes

    Louis Monnier;Claude Colette;Gareth John Dunseath;David Raymond Owens

  • Monomeric insulins and their experimental and clinical implications.

    Jens Brange;David R Owens;Steven Kang;Aage Vølund

  • Insulins today and beyond

    David R Owens;Bernard Zinman;Geremia B Bolli

  • Postprandial Glucose Regulation and Diabetic Complications

    Antonio Ceriello;Markolf Hanefeld;Lawrence Leiter;Louis Monnier

  • Glycaemic variability in diabetes: clinical and therapeutic implications

    Antonio Ceriello;Louis Monnier;David Owens

  • Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

    Reinhard G. Bretzel;Ulrike Nuber;Wolfgang Landgraf;David Raymond Owens

  • Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes

    Louis Monnier;Claude Colette;Anne Wojtusciszyn;Sylvie Dejager

  • Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it?:

    Louis Monnier;Claude Colette;David Raymond Owens

  • Efficacy and safety of linagliptin in persons with Type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24‐week randomized study1

    David Raymond Owens;R. Swallow;K. A. Dugi;H. J. Woerle

  • IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018.

    R.L. Thomas;S. Halim;S. Gurudas;S. Sivaprasad

  • Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

    Francesca Porcellati;Paolo Rossetti;Natalia Ricci Busciantella;Stefania Marzotti

  • New horizons — alternative routes for insulin therapy

    David R. Owens

  • Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses

    Natalie Nanayakkara;Natalie Nanayakkara;Andrea J. Curtis;Stephane Heritier;Adelle M. Gadowski

  • Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus.

    Jiten P. Vora;John Dolben;John D. Dean;David Thomas

  • Postprandial glucose regulation: new data and new implications.

    Lawrence A. Leiter;Antonio Ceriello;Jaime A. Davidson;Markolf Hanefeld

  • Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service

    Rebecca L. Thomas;Frank David John Dunstan;Stephen Denis Luzio;S. R. Chowdhury

  • Anemia and diabetes in the absence of nephropathy.

    Kathrine Jane Craig;John David Williams;Stephen George Riley;Hilary Smith

  • How soon after myocardial infarction should plasma lipid values be assessed

    R E Ryder;T M Hayes;I P Mulligan;J C Kingswood

Frequent Co-Authors

Geremia B. Bolli
Geremia B. Bolli University of Perugia
Antonio Ceriello
Antonio Ceriello MultiMedica
Ian Jones
Ian Jones Cardiff University
Philip Home
Philip Home Newcastle University
Hans-Juergen Woerle
Hans-Juergen Woerle Nestlé (Switzerland)
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Peter Boyle
Peter Boyle University of Edinburgh
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Omer F. Rana
Omer F. Rana Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers diverse opportunities that go beyond the traditional MD path. Today, several cheapest online mha programs make it possible to step into healthcare leadership and administrative roles without leaving your day job.

Nursing professionals may consider advancing their expertise through some of the best online dnp programs. These doctoral degrees can open doors to specialized clinical or academic positions.

For those interested in the pharmaceutical industry, online pharmacy programs provide flexible options to earn a Doctorate of Pharmacy, potentially leading to high-demand roles in clinics, hospitals, and research.

Additionally, with healthcare delivery increasingly relying on technology and data, earning a health information management degree online prepares graduates for vital jobs in health data management, privacy, and analytics.

These online degree pathways offer affordability, flexibility, and a direct route to rewarding careers outside traditional clinical medicine.

Best Scientists Citing David R. Owens

Trending Scientists